Low STK17B was similarly correlated with worse DSS in T and M Stage, pathologic stage, melanoma Clark level, Breslow depth, melanoma ulceration, tumor site, BRAF status, age, race, gender, radiation therapy of SKCM patients (Fig 3). This evidence concerns the gene BRAF and neoplasm.